nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—PTGS1—Etoposide—urinary bladder cancer	0.0734	0.193	CbGbCtD
Zopiclone—CYP3A4—Thiotepa—urinary bladder cancer	0.0634	0.166	CbGbCtD
Zopiclone—CYP2E1—Etoposide—urinary bladder cancer	0.0567	0.149	CbGbCtD
Zopiclone—CYP2C8—Fluorouracil—urinary bladder cancer	0.0508	0.133	CbGbCtD
Zopiclone—CYP2C8—Etoposide—urinary bladder cancer	0.0424	0.111	CbGbCtD
Zopiclone—CYP2C9—Fluorouracil—urinary bladder cancer	0.0354	0.0929	CbGbCtD
Zopiclone—CYP2C9—Cisplatin—urinary bladder cancer	0.0301	0.0789	CbGbCtD
Zopiclone—CYP3A4—Etoposide—urinary bladder cancer	0.0172	0.0451	CbGbCtD
Zopiclone—CYP3A4—Doxorubicin—urinary bladder cancer	0.0117	0.0308	CbGbCtD
Zopiclone—CYP2C9—urine—urinary bladder cancer	0.00502	0.0845	CbGeAlD
Zopiclone—CYP2E1—urine—urinary bladder cancer	0.00475	0.0801	CbGeAlD
Zopiclone—CYP3A4—urine—urinary bladder cancer	0.00383	0.0644	CbGeAlD
Zopiclone—TSPO—prostate gland—urinary bladder cancer	0.00295	0.0498	CbGeAlD
Zopiclone—GABRB3—prostate gland—urinary bladder cancer	0.00268	0.0452	CbGeAlD
Zopiclone—TSPO—seminal vesicle—urinary bladder cancer	0.0025	0.0421	CbGeAlD
Zopiclone—TSPO—epithelium—urinary bladder cancer	0.00217	0.0366	CbGeAlD
Zopiclone—TSPO—smooth muscle tissue—urinary bladder cancer	0.00209	0.0352	CbGeAlD
Zopiclone—TSPO—renal system—urinary bladder cancer	0.00201	0.0339	CbGeAlD
Zopiclone—TSPO—urethra—urinary bladder cancer	0.00198	0.0333	CbGeAlD
Zopiclone—CYP2E1—prostate gland—urinary bladder cancer	0.00171	0.0288	CbGeAlD
Zopiclone—PTGS1—prostate gland—urinary bladder cancer	0.00164	0.0277	CbGeAlD
Zopiclone—TSPO—female reproductive system—urinary bladder cancer	0.00161	0.0272	CbGeAlD
Zopiclone—GABRA2—vagina—urinary bladder cancer	0.00158	0.0265	CbGeAlD
Zopiclone—GABRB3—female reproductive system—urinary bladder cancer	0.00146	0.0247	CbGeAlD
Zopiclone—TSPO—vagina—urinary bladder cancer	0.00146	0.0246	CbGeAlD
Zopiclone—CYP2E1—seminal vesicle—urinary bladder cancer	0.00144	0.0243	CbGeAlD
Zopiclone—PTGS1—seminal vesicle—urinary bladder cancer	0.00139	0.0234	CbGeAlD
Zopiclone—CYP2C8—renal system—urinary bladder cancer	0.00138	0.0233	CbGeAlD
Zopiclone—PTGS1—epithelium—urinary bladder cancer	0.00121	0.0204	CbGeAlD
Zopiclone—PTGS1—smooth muscle tissue—urinary bladder cancer	0.00116	0.0196	CbGeAlD
Zopiclone—CYP2E1—renal system—urinary bladder cancer	0.00116	0.0196	CbGeAlD
Zopiclone—CYP2E1—urethra—urinary bladder cancer	0.00114	0.0193	CbGeAlD
Zopiclone—PTGS1—renal system—urinary bladder cancer	0.00112	0.0189	CbGeAlD
Zopiclone—CYP2C8—female reproductive system—urinary bladder cancer	0.00111	0.0186	CbGeAlD
Zopiclone—GABRA2—lymph node—urinary bladder cancer	0.00102	0.0172	CbGeAlD
Zopiclone—CYP2C8—vagina—urinary bladder cancer	0.001	0.0169	CbGeAlD
Zopiclone—CYP2C9—female reproductive system—urinary bladder cancer	0.000983	0.0166	CbGeAlD
Zopiclone—TSPO—lymph node—urinary bladder cancer	0.000944	0.0159	CbGeAlD
Zopiclone—CYP3A4—renal system—urinary bladder cancer	0.000936	0.0158	CbGeAlD
Zopiclone—CYP2E1—female reproductive system—urinary bladder cancer	0.000932	0.0157	CbGeAlD
Zopiclone—PTGS1—female reproductive system—urinary bladder cancer	0.000898	0.0151	CbGeAlD
Zopiclone—PTGS1—vagina—urinary bladder cancer	0.000812	0.0137	CbGeAlD
Zopiclone—CYP3A4—female reproductive system—urinary bladder cancer	0.00075	0.0126	CbGeAlD
Zopiclone—PTGS1—lymph node—urinary bladder cancer	0.000525	0.00884	CbGeAlD
Zopiclone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000339	0.000699	CcSEcCtD
Zopiclone—Sweating—Methotrexate—urinary bladder cancer	0.000335	0.000692	CcSEcCtD
Zopiclone—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000335	0.000691	CcSEcCtD
Zopiclone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000335	0.000691	CcSEcCtD
Zopiclone—Paraesthesia—Etoposide—urinary bladder cancer	0.000335	0.00069	CcSEcCtD
Zopiclone—Weight increased—Epirubicin—urinary bladder cancer	0.000334	0.000689	CcSEcCtD
Zopiclone—Haematuria—Methotrexate—urinary bladder cancer	0.000334	0.000688	CcSEcCtD
Zopiclone—Weight decreased—Epirubicin—urinary bladder cancer	0.000332	0.000685	CcSEcCtD
Zopiclone—Dyspnoea—Etoposide—urinary bladder cancer	0.000332	0.000685	CcSEcCtD
Zopiclone—Somnolence—Etoposide—urinary bladder cancer	0.000331	0.000683	CcSEcCtD
Zopiclone—Epistaxis—Methotrexate—urinary bladder cancer	0.00033	0.00068	CcSEcCtD
Zopiclone—Vomiting—Thiotepa—urinary bladder cancer	0.00033	0.00068	CcSEcCtD
Zopiclone—Drowsiness—Epirubicin—urinary bladder cancer	0.000327	0.000675	CcSEcCtD
Zopiclone—Rash—Thiotepa—urinary bladder cancer	0.000327	0.000674	CcSEcCtD
Zopiclone—Bronchitis—Doxorubicin—urinary bladder cancer	0.000327	0.000674	CcSEcCtD
Zopiclone—Dermatitis—Thiotepa—urinary bladder cancer	0.000327	0.000674	CcSEcCtD
Zopiclone—Headache—Thiotepa—urinary bladder cancer	0.000325	0.00067	CcSEcCtD
Zopiclone—Decreased appetite—Etoposide—urinary bladder cancer	0.000324	0.000668	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000322	0.000663	CcSEcCtD
Zopiclone—Body temperature increased—Cisplatin—urinary bladder cancer	0.000321	0.000663	CcSEcCtD
Zopiclone—Fatigue—Etoposide—urinary bladder cancer	0.000321	0.000662	CcSEcCtD
Zopiclone—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000321	0.000662	CcSEcCtD
Zopiclone—Stomatitis—Epirubicin—urinary bladder cancer	0.000319	0.000658	CcSEcCtD
Zopiclone—Constipation—Etoposide—urinary bladder cancer	0.000319	0.000657	CcSEcCtD
Zopiclone—Pain—Etoposide—urinary bladder cancer	0.000319	0.000657	CcSEcCtD
Zopiclone—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000318	0.000656	CcSEcCtD
Zopiclone—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000318	0.000656	CcSEcCtD
Zopiclone—Dysuria—Doxorubicin—urinary bladder cancer	0.000318	0.000655	CcSEcCtD
Zopiclone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000316	0.000652	CcSEcCtD
Zopiclone—Hepatitis—Methotrexate—urinary bladder cancer	0.000314	0.000648	CcSEcCtD
Zopiclone—Sweating—Epirubicin—urinary bladder cancer	0.000314	0.000647	CcSEcCtD
Zopiclone—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000314	0.000647	CcSEcCtD
Zopiclone—Asthenia—Gemcitabine—urinary bladder cancer	0.000313	0.000645	CcSEcCtD
Zopiclone—Haematuria—Epirubicin—urinary bladder cancer	0.000312	0.000644	CcSEcCtD
Zopiclone—Pharyngitis—Methotrexate—urinary bladder cancer	0.000312	0.000643	CcSEcCtD
Zopiclone—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00031	0.00064	CcSEcCtD
Zopiclone—Weight increased—Doxorubicin—urinary bladder cancer	0.000309	0.000638	CcSEcCtD
Zopiclone—Epistaxis—Epirubicin—urinary bladder cancer	0.000309	0.000637	CcSEcCtD
Zopiclone—Pruritus—Gemcitabine—urinary bladder cancer	0.000309	0.000636	CcSEcCtD
Zopiclone—Nausea—Thiotepa—urinary bladder cancer	0.000308	0.000635	CcSEcCtD
Zopiclone—Weight decreased—Doxorubicin—urinary bladder cancer	0.000307	0.000634	CcSEcCtD
Zopiclone—Feeling abnormal—Etoposide—urinary bladder cancer	0.000307	0.000633	CcSEcCtD
Zopiclone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000305	0.000628	CcSEcCtD
Zopiclone—Pruritus—Fluorouracil—urinary bladder cancer	0.000303	0.000626	CcSEcCtD
Zopiclone—Drowsiness—Doxorubicin—urinary bladder cancer	0.000303	0.000625	CcSEcCtD
Zopiclone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0003	0.000618	CcSEcCtD
Zopiclone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000299	0.000616	CcSEcCtD
Zopiclone—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000297	0.000612	CcSEcCtD
Zopiclone—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000297	0.000612	CcSEcCtD
Zopiclone—Urticaria—Etoposide—urinary bladder cancer	0.000296	0.00061	CcSEcCtD
Zopiclone—Stomatitis—Doxorubicin—urinary bladder cancer	0.000295	0.000609	CcSEcCtD
Zopiclone—Rhinitis—Epirubicin—urinary bladder cancer	0.000295	0.000608	CcSEcCtD
Zopiclone—Abdominal pain—Etoposide—urinary bladder cancer	0.000295	0.000607	CcSEcCtD
Zopiclone—Body temperature increased—Etoposide—urinary bladder cancer	0.000295	0.000607	CcSEcCtD
Zopiclone—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000294	0.000607	CcSEcCtD
Zopiclone—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000294	0.000607	CcSEcCtD
Zopiclone—Hepatitis—Epirubicin—urinary bladder cancer	0.000294	0.000606	CcSEcCtD
Zopiclone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000294	0.000605	CcSEcCtD
Zopiclone—Tinnitus—Methotrexate—urinary bladder cancer	0.000293	0.000604	CcSEcCtD
Zopiclone—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000292	0.000603	CcSEcCtD
Zopiclone—Asthenia—Cisplatin—urinary bladder cancer	0.000292	0.000602	CcSEcCtD
Zopiclone—Pharyngitis—Epirubicin—urinary bladder cancer	0.000292	0.000602	CcSEcCtD
Zopiclone—Sweating—Doxorubicin—urinary bladder cancer	0.00029	0.000599	CcSEcCtD
Zopiclone—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00029	0.000597	CcSEcCtD
Zopiclone—Haematuria—Doxorubicin—urinary bladder cancer	0.000289	0.000596	CcSEcCtD
Zopiclone—Epistaxis—Doxorubicin—urinary bladder cancer	0.000286	0.000589	CcSEcCtD
Zopiclone—Dizziness—Fluorouracil—urinary bladder cancer	0.000284	0.000585	CcSEcCtD
Zopiclone—Chills—Methotrexate—urinary bladder cancer	0.000282	0.000581	CcSEcCtD
Zopiclone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000278	0.000574	CcSEcCtD
Zopiclone—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000278	0.000573	CcSEcCtD
Zopiclone—Alopecia—Methotrexate—urinary bladder cancer	0.000278	0.000572	CcSEcCtD
Zopiclone—Vomiting—Gemcitabine—urinary bladder cancer	0.000277	0.000572	CcSEcCtD
Zopiclone—Rash—Gemcitabine—urinary bladder cancer	0.000275	0.000567	CcSEcCtD
Zopiclone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000275	0.000567	CcSEcCtD
Zopiclone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000274	0.000566	CcSEcCtD
Zopiclone—Tinnitus—Epirubicin—urinary bladder cancer	0.000274	0.000565	CcSEcCtD
Zopiclone—Headache—Gemcitabine—urinary bladder cancer	0.000273	0.000564	CcSEcCtD
Zopiclone—Vomiting—Fluorouracil—urinary bladder cancer	0.000273	0.000562	CcSEcCtD
Zopiclone—Rhinitis—Doxorubicin—urinary bladder cancer	0.000273	0.000562	CcSEcCtD
Zopiclone—Hepatitis—Doxorubicin—urinary bladder cancer	0.000272	0.000561	CcSEcCtD
Zopiclone—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000271	0.000558	CcSEcCtD
Zopiclone—Rash—Fluorouracil—urinary bladder cancer	0.00027	0.000558	CcSEcCtD
Zopiclone—Dermatitis—Fluorouracil—urinary bladder cancer	0.00027	0.000557	CcSEcCtD
Zopiclone—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00027	0.000557	CcSEcCtD
Zopiclone—Headache—Fluorouracil—urinary bladder cancer	0.000269	0.000554	CcSEcCtD
Zopiclone—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000268	0.000552	CcSEcCtD
Zopiclone—Dysgeusia—Methotrexate—urinary bladder cancer	0.000268	0.000552	CcSEcCtD
Zopiclone—Asthenia—Etoposide—urinary bladder cancer	0.000267	0.000551	CcSEcCtD
Zopiclone—Back pain—Methotrexate—urinary bladder cancer	0.000264	0.000545	CcSEcCtD
Zopiclone—Chills—Epirubicin—urinary bladder cancer	0.000264	0.000544	CcSEcCtD
Zopiclone—Pruritus—Etoposide—urinary bladder cancer	0.000264	0.000543	CcSEcCtD
Zopiclone—Alopecia—Epirubicin—urinary bladder cancer	0.00026	0.000536	CcSEcCtD
Zopiclone—Nausea—Gemcitabine—urinary bladder cancer	0.000259	0.000534	CcSEcCtD
Zopiclone—Vomiting—Cisplatin—urinary bladder cancer	0.000259	0.000533	CcSEcCtD
Zopiclone—Vision blurred—Methotrexate—urinary bladder cancer	0.000258	0.000531	CcSEcCtD
Zopiclone—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000257	0.00053	CcSEcCtD
Zopiclone—Rash—Cisplatin—urinary bladder cancer	0.000256	0.000529	CcSEcCtD
Zopiclone—Dermatitis—Cisplatin—urinary bladder cancer	0.000256	0.000528	CcSEcCtD
Zopiclone—Diarrhoea—Etoposide—urinary bladder cancer	0.000255	0.000526	CcSEcCtD
Zopiclone—Nausea—Fluorouracil—urinary bladder cancer	0.000255	0.000525	CcSEcCtD
Zopiclone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000254	0.000523	CcSEcCtD
Zopiclone—Tinnitus—Doxorubicin—urinary bladder cancer	0.000254	0.000523	CcSEcCtD
Zopiclone—Anaemia—Methotrexate—urinary bladder cancer	0.000253	0.000521	CcSEcCtD
Zopiclone—Tension—Epirubicin—urinary bladder cancer	0.000251	0.000518	CcSEcCtD
Zopiclone—Dysgeusia—Epirubicin—urinary bladder cancer	0.000251	0.000517	CcSEcCtD
Zopiclone—Nervousness—Epirubicin—urinary bladder cancer	0.000249	0.000512	CcSEcCtD
Zopiclone—Back pain—Epirubicin—urinary bladder cancer	0.000248	0.00051	CcSEcCtD
Zopiclone—Malaise—Methotrexate—urinary bladder cancer	0.000247	0.000508	CcSEcCtD
Zopiclone—Dizziness—Etoposide—urinary bladder cancer	0.000246	0.000508	CcSEcCtD
Zopiclone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000246	0.000507	CcSEcCtD
Zopiclone—Vertigo—Methotrexate—urinary bladder cancer	0.000246	0.000507	CcSEcCtD
Zopiclone—Chills—Doxorubicin—urinary bladder cancer	0.000244	0.000503	CcSEcCtD
Zopiclone—Nausea—Cisplatin—urinary bladder cancer	0.000242	0.000498	CcSEcCtD
Zopiclone—Vision blurred—Epirubicin—urinary bladder cancer	0.000241	0.000497	CcSEcCtD
Zopiclone—Alopecia—Doxorubicin—urinary bladder cancer	0.00024	0.000496	CcSEcCtD
Zopiclone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000237	0.00049	CcSEcCtD
Zopiclone—Convulsion—Methotrexate—urinary bladder cancer	0.000237	0.000488	CcSEcCtD
Zopiclone—Vomiting—Etoposide—urinary bladder cancer	0.000237	0.000488	CcSEcCtD
Zopiclone—Anaemia—Epirubicin—urinary bladder cancer	0.000237	0.000488	CcSEcCtD
Zopiclone—Agitation—Epirubicin—urinary bladder cancer	0.000235	0.000485	CcSEcCtD
Zopiclone—Rash—Etoposide—urinary bladder cancer	0.000235	0.000484	CcSEcCtD
Zopiclone—Dermatitis—Etoposide—urinary bladder cancer	0.000235	0.000484	CcSEcCtD
Zopiclone—Headache—Etoposide—urinary bladder cancer	0.000233	0.000481	CcSEcCtD
Zopiclone—Myalgia—Methotrexate—urinary bladder cancer	0.000233	0.00048	CcSEcCtD
Zopiclone—Chest pain—Methotrexate—urinary bladder cancer	0.000233	0.00048	CcSEcCtD
Zopiclone—Tension—Doxorubicin—urinary bladder cancer	0.000232	0.000479	CcSEcCtD
Zopiclone—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000232	0.000478	CcSEcCtD
Zopiclone—Malaise—Epirubicin—urinary bladder cancer	0.000231	0.000476	CcSEcCtD
Zopiclone—Discomfort—Methotrexate—urinary bladder cancer	0.00023	0.000474	CcSEcCtD
Zopiclone—Nervousness—Doxorubicin—urinary bladder cancer	0.00023	0.000474	CcSEcCtD
Zopiclone—Vertigo—Epirubicin—urinary bladder cancer	0.00023	0.000474	CcSEcCtD
Zopiclone—Back pain—Doxorubicin—urinary bladder cancer	0.000229	0.000472	CcSEcCtD
Zopiclone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000228	0.000469	CcSEcCtD
Zopiclone—Palpitations—Epirubicin—urinary bladder cancer	0.000226	0.000466	CcSEcCtD
Zopiclone—Confusional state—Methotrexate—urinary bladder cancer	0.000225	0.000464	CcSEcCtD
Zopiclone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000223	0.00046	CcSEcCtD
Zopiclone—Vision blurred—Doxorubicin—urinary bladder cancer	0.000223	0.00046	CcSEcCtD
Zopiclone—Convulsion—Epirubicin—urinary bladder cancer	0.000222	0.000457	CcSEcCtD
Zopiclone—Infection—Methotrexate—urinary bladder cancer	0.000222	0.000457	CcSEcCtD
Zopiclone—Nausea—Etoposide—urinary bladder cancer	0.000221	0.000456	CcSEcCtD
Zopiclone—Hypertension—Epirubicin—urinary bladder cancer	0.000221	0.000456	CcSEcCtD
Zopiclone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00022	0.000453	CcSEcCtD
Zopiclone—Anaemia—Doxorubicin—urinary bladder cancer	0.000219	0.000451	CcSEcCtD
Zopiclone—Chest pain—Epirubicin—urinary bladder cancer	0.000218	0.000449	CcSEcCtD
Zopiclone—Myalgia—Epirubicin—urinary bladder cancer	0.000218	0.000449	CcSEcCtD
Zopiclone—Agitation—Doxorubicin—urinary bladder cancer	0.000218	0.000449	CcSEcCtD
Zopiclone—Anxiety—Epirubicin—urinary bladder cancer	0.000217	0.000448	CcSEcCtD
Zopiclone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000216	0.000445	CcSEcCtD
Zopiclone—Discomfort—Epirubicin—urinary bladder cancer	0.000215	0.000444	CcSEcCtD
Zopiclone—Malaise—Doxorubicin—urinary bladder cancer	0.000214	0.00044	CcSEcCtD
Zopiclone—Dry mouth—Epirubicin—urinary bladder cancer	0.000213	0.000439	CcSEcCtD
Zopiclone—Vertigo—Doxorubicin—urinary bladder cancer	0.000213	0.000439	CcSEcCtD
Zopiclone—Anorexia—Methotrexate—urinary bladder cancer	0.000213	0.000439	CcSEcCtD
Zopiclone—Confusional state—Epirubicin—urinary bladder cancer	0.000211	0.000434	CcSEcCtD
Zopiclone—Palpitations—Doxorubicin—urinary bladder cancer	0.000209	0.000431	CcSEcCtD
Zopiclone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000209	0.000431	CcSEcCtD
Zopiclone—Infection—Epirubicin—urinary bladder cancer	0.000207	0.000428	CcSEcCtD
Zopiclone—Convulsion—Doxorubicin—urinary bladder cancer	0.000205	0.000423	CcSEcCtD
Zopiclone—Hypertension—Doxorubicin—urinary bladder cancer	0.000204	0.000421	CcSEcCtD
Zopiclone—Tachycardia—Epirubicin—urinary bladder cancer	0.000204	0.00042	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000203	0.000419	CcSEcCtD
Zopiclone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000202	0.000416	CcSEcCtD
Zopiclone—Insomnia—Methotrexate—urinary bladder cancer	0.000202	0.000416	CcSEcCtD
Zopiclone—Chest pain—Doxorubicin—urinary bladder cancer	0.000202	0.000416	CcSEcCtD
Zopiclone—Myalgia—Doxorubicin—urinary bladder cancer	0.000202	0.000416	CcSEcCtD
Zopiclone—Anxiety—Doxorubicin—urinary bladder cancer	0.000201	0.000414	CcSEcCtD
Zopiclone—Paraesthesia—Methotrexate—urinary bladder cancer	0.0002	0.000413	CcSEcCtD
Zopiclone—Discomfort—Doxorubicin—urinary bladder cancer	0.000199	0.000411	CcSEcCtD
Zopiclone—Anorexia—Epirubicin—urinary bladder cancer	0.000199	0.00041	CcSEcCtD
Zopiclone—Dyspnoea—Methotrexate—urinary bladder cancer	0.000199	0.00041	CcSEcCtD
Zopiclone—Somnolence—Methotrexate—urinary bladder cancer	0.000198	0.000409	CcSEcCtD
Zopiclone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000197	0.000406	CcSEcCtD
Zopiclone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000196	0.000405	CcSEcCtD
Zopiclone—Confusional state—Doxorubicin—urinary bladder cancer	0.000195	0.000402	CcSEcCtD
Zopiclone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000194	0.0004	CcSEcCtD
Zopiclone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000193	0.000398	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000193	0.000397	CcSEcCtD
Zopiclone—Fatigue—Methotrexate—urinary bladder cancer	0.000192	0.000397	CcSEcCtD
Zopiclone—Infection—Doxorubicin—urinary bladder cancer	0.000192	0.000396	CcSEcCtD
Zopiclone—Pain—Methotrexate—urinary bladder cancer	0.000191	0.000393	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00019	0.000392	CcSEcCtD
Zopiclone—Insomnia—Epirubicin—urinary bladder cancer	0.000189	0.000389	CcSEcCtD
Zopiclone—Tachycardia—Doxorubicin—urinary bladder cancer	0.000189	0.000389	CcSEcCtD
Zopiclone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000188	0.000387	CcSEcCtD
Zopiclone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000187	0.000385	CcSEcCtD
Zopiclone—Dyspnoea—Epirubicin—urinary bladder cancer	0.000186	0.000384	CcSEcCtD
Zopiclone—Somnolence—Epirubicin—urinary bladder cancer	0.000186	0.000383	CcSEcCtD
Zopiclone—Anorexia—Doxorubicin—urinary bladder cancer	0.000184	0.00038	CcSEcCtD
Zopiclone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000184	0.000379	CcSEcCtD
Zopiclone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000184	0.000379	CcSEcCtD
Zopiclone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000182	0.000376	CcSEcCtD
Zopiclone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000182	0.000374	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00018	0.000372	CcSEcCtD
Zopiclone—Fatigue—Epirubicin—urinary bladder cancer	0.00018	0.000371	CcSEcCtD
Zopiclone—Pain—Epirubicin—urinary bladder cancer	0.000179	0.000368	CcSEcCtD
Zopiclone—Constipation—Epirubicin—urinary bladder cancer	0.000179	0.000368	CcSEcCtD
Zopiclone—Urticaria—Methotrexate—urinary bladder cancer	0.000177	0.000366	CcSEcCtD
Zopiclone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000176	0.000364	CcSEcCtD
Zopiclone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000176	0.000364	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000176	0.000363	CcSEcCtD
Zopiclone—Insomnia—Doxorubicin—urinary bladder cancer	0.000175	0.00036	CcSEcCtD
Zopiclone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000174	0.000358	CcSEcCtD
Zopiclone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000172	0.000355	CcSEcCtD
Zopiclone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000172	0.000355	CcSEcCtD
Zopiclone—Somnolence—Doxorubicin—urinary bladder cancer	0.000172	0.000354	CcSEcCtD
Zopiclone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000171	0.000352	CcSEcCtD
Zopiclone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00017	0.000351	CcSEcCtD
Zopiclone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000168	0.000346	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000167	0.000344	CcSEcCtD
Zopiclone—Fatigue—Doxorubicin—urinary bladder cancer	0.000167	0.000344	CcSEcCtD
Zopiclone—Urticaria—Epirubicin—urinary bladder cancer	0.000166	0.000342	CcSEcCtD
Zopiclone—Constipation—Doxorubicin—urinary bladder cancer	0.000165	0.000341	CcSEcCtD
Zopiclone—Pain—Doxorubicin—urinary bladder cancer	0.000165	0.000341	CcSEcCtD
Zopiclone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000165	0.00034	CcSEcCtD
Zopiclone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000165	0.00034	CcSEcCtD
Zopiclone—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	0.000165	0.00222	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000165	0.00221	CbGpPWpGaD
Zopiclone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000164	0.000339	CcSEcCtD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000164	0.00221	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000163	0.00218	CbGpPWpGaD
Zopiclone—GABRA1—Orphan transporters—CREBBP—urinary bladder cancer	0.000162	0.00218	CbGpPWpGaD
Zopiclone—Asthenia—Methotrexate—urinary bladder cancer	0.00016	0.00033	CcSEcCtD
Zopiclone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000159	0.000328	CcSEcCtD
Zopiclone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000158	0.000326	CcSEcCtD
Zopiclone—Pruritus—Methotrexate—urinary bladder cancer	0.000158	0.000326	CcSEcCtD
Zopiclone—GABRB2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000157	0.00211	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000154	0.00207	CbGpPWpGaD
Zopiclone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000154	0.000317	CcSEcCtD
Zopiclone—Urticaria—Doxorubicin—urinary bladder cancer	0.000154	0.000317	CcSEcCtD
Zopiclone—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000153	0.00206	CbGpPWpGaD
Zopiclone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000153	0.000315	CcSEcCtD
Zopiclone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000153	0.000315	CcSEcCtD
Zopiclone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000153	0.000315	CcSEcCtD
Zopiclone—GABRA5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000152	0.00205	CbGpPWpGaD
Zopiclone—Asthenia—Epirubicin—urinary bladder cancer	0.00015	0.000309	CcSEcCtD
Zopiclone—GABRA3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00015	0.00201	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.00015	0.00201	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000148	0.00199	CbGpPWpGaD
Zopiclone—Pruritus—Epirubicin—urinary bladder cancer	0.000148	0.000305	CcSEcCtD
Zopiclone—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000148	0.00198	CbGpPWpGaD
Zopiclone—Dizziness—Methotrexate—urinary bladder cancer	0.000148	0.000304	CcSEcCtD
Zopiclone—GABRA2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000147	0.00198	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—HPGDS—urinary bladder cancer	0.000147	0.00197	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000146	0.00197	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000146	0.00196	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000144	0.00193	CbGpPWpGaD
Zopiclone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000143	0.000295	CcSEcCtD
Zopiclone—CYP2C8—Biological oxidations—GSTT1—urinary bladder cancer	0.000143	0.00192	CbGpPWpGaD
Zopiclone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000142	0.000294	CcSEcCtD
Zopiclone—Vomiting—Methotrexate—urinary bladder cancer	0.000142	0.000293	CcSEcCtD
Zopiclone—Rash—Methotrexate—urinary bladder cancer	0.000141	0.00029	CcSEcCtD
Zopiclone—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000141	0.00189	CbGpPWpGaD
Zopiclone—Dermatitis—Methotrexate—urinary bladder cancer	0.000141	0.00029	CcSEcCtD
Zopiclone—Headache—Methotrexate—urinary bladder cancer	0.00014	0.000288	CcSEcCtD
Zopiclone—Asthenia—Doxorubicin—urinary bladder cancer	0.000139	0.000286	CcSEcCtD
Zopiclone—Dizziness—Epirubicin—urinary bladder cancer	0.000138	0.000285	CcSEcCtD
Zopiclone—CYP2C8—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000138	0.00185	CbGpPWpGaD
Zopiclone—Pruritus—Doxorubicin—urinary bladder cancer	0.000137	0.000282	CcSEcCtD
Zopiclone—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000136	0.00182	CbGpPWpGaD
Zopiclone—Vomiting—Epirubicin—urinary bladder cancer	0.000133	0.000274	CcSEcCtD
Zopiclone—Nausea—Methotrexate—urinary bladder cancer	0.000133	0.000273	CcSEcCtD
Zopiclone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000132	0.000273	CcSEcCtD
Zopiclone—Rash—Epirubicin—urinary bladder cancer	0.000132	0.000272	CcSEcCtD
Zopiclone—Dermatitis—Epirubicin—urinary bladder cancer	0.000132	0.000271	CcSEcCtD
Zopiclone—Headache—Epirubicin—urinary bladder cancer	0.000131	0.00027	CcSEcCtD
Zopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000128	0.00172	CbGpPWpGaD
Zopiclone—Dizziness—Doxorubicin—urinary bladder cancer	0.000128	0.000263	CcSEcCtD
Zopiclone—GABRG3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000126	0.00169	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000125	0.00168	CbGpPWpGaD
Zopiclone—Nausea—Epirubicin—urinary bladder cancer	0.000124	0.000256	CcSEcCtD
Zopiclone—Vomiting—Doxorubicin—urinary bladder cancer	0.000123	0.000253	CcSEcCtD
Zopiclone—Rash—Doxorubicin—urinary bladder cancer	0.000122	0.000251	CcSEcCtD
Zopiclone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000122	0.000251	CcSEcCtD
Zopiclone—Headache—Doxorubicin—urinary bladder cancer	0.000121	0.00025	CcSEcCtD
Zopiclone—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.00012	0.00161	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000117	0.00158	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000116	0.00156	CbGpPWpGaD
Zopiclone—Nausea—Doxorubicin—urinary bladder cancer	0.000115	0.000237	CcSEcCtD
Zopiclone—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	0.000114	0.00154	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000113	0.00151	CbGpPWpGaD
Zopiclone—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000112	0.0015	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000106	0.00143	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000106	0.00142	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	0.000105	0.00141	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000104	0.00139	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000103	0.00138	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000101	0.00136	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.94e-05	0.00133	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—GSTP1—urinary bladder cancer	9.89e-05	0.00133	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.87e-05	0.00133	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	9.87e-05	0.00133	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.75e-05	0.00131	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	9.74e-05	0.00131	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.7e-05	0.0013	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	9.66e-05	0.0013	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	9.38e-05	0.00126	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	9.33e-05	0.00125	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.15e-05	0.00123	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	9.08e-05	0.00122	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.96e-05	0.0012	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTO2—urinary bladder cancer	8.89e-05	0.00119	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NAT1—urinary bladder cancer	8.89e-05	0.00119	CbGpPWpGaD
Zopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.87e-05	0.00119	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.74e-05	0.00117	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.64e-05	0.00116	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.48e-05	0.00114	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	8.13e-05	0.00109	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	8.05e-05	0.00108	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	8e-05	0.00107	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.93e-05	0.00107	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	7.89e-05	0.00106	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	7.65e-05	0.00103	CbGpPWpGaD
Zopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.47e-05	0.001	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	7.39e-05	0.000993	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	7.32e-05	0.000983	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.29e-05	0.000979	CbGpPWpGaD
Zopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.25e-05	0.000974	CbGpPWpGaD
Zopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.12e-05	0.000957	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	7.01e-05	0.000941	CbGpPWpGaD
Zopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7e-05	0.00094	CbGpPWpGaD
Zopiclone—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.96e-05	0.000934	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	6.91e-05	0.000928	CbGpPWpGaD
Zopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.83e-05	0.000917	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	6.8e-05	0.000913	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PRSS3—urinary bladder cancer	6.74e-05	0.000904	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.67e-05	0.000896	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	6.64e-05	0.000892	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NAT1—urinary bladder cancer	6.64e-05	0.000892	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	6.49e-05	0.000872	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	6.07e-05	0.000816	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	6.06e-05	0.000813	CbGpPWpGaD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.97e-05	0.000802	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.89e-05	0.000791	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	5.74e-05	0.000771	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NAT1—urinary bladder cancer	5.74e-05	0.000771	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.65e-05	0.000758	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.61e-05	0.000754	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	5.47e-05	0.000734	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.45e-05	0.000732	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.4e-05	0.000725	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—TYMP—urinary bladder cancer	5.38e-05	0.000723	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.36e-05	0.000719	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.31e-05	0.000712	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.26e-05	0.000707	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	5.25e-05	0.000705	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.23e-05	0.000703	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.23e-05	0.000702	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.17e-05	0.000694	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	5.16e-05	0.000694	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.13e-05	0.000689	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—HRAS—urinary bladder cancer	5.11e-05	0.000686	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	5.03e-05	0.000676	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.96e-05	0.000666	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	4.93e-05	0.000662	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.88e-05	0.000655	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NAT2—urinary bladder cancer	4.87e-05	0.000654	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.82e-05	0.000647	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.81e-05	0.000646	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.73e-05	0.000636	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	4.73e-05	0.000635	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.67e-05	0.000627	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.67e-05	0.000627	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.65e-05	0.000625	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.62e-05	0.000621	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.6e-05	0.000617	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.54e-05	0.000609	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.49e-05	0.000603	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	4.46e-05	0.000599	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	4.35e-05	0.000584	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—HRAS—urinary bladder cancer	4.3e-05	0.000578	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.27e-05	0.000574	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—RRM2—urinary bladder cancer	4.2e-05	0.000564	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—HRAS—urinary bladder cancer	4.18e-05	0.000561	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—HRAS—urinary bladder cancer	4.1e-05	0.000551	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—HRAS—urinary bladder cancer	4.03e-05	0.000541	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TYMP—urinary bladder cancer	4.02e-05	0.00054	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—HRAS—urinary bladder cancer	4.01e-05	0.000538	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.97e-05	0.000533	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—HRAS—urinary bladder cancer	3.93e-05	0.000528	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.89e-05	0.000523	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.89e-05	0.000523	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.87e-05	0.00052	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.85e-05	0.000517	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.78e-05	0.000507	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.72e-05	0.000499	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NAT2—urinary bladder cancer	3.64e-05	0.000489	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.63e-05	0.000488	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.54e-05	0.000475	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.49e-05	0.000468	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.48e-05	0.000467	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—HRAS—urinary bladder cancer	3.44e-05	0.000462	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.34e-05	0.000449	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.25e-05	0.000436	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NAT2—urinary bladder cancer	3.15e-05	0.000422	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—RRM2—urinary bladder cancer	3.14e-05	0.000422	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NQO1—urinary bladder cancer	3.14e-05	0.000421	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.08e-05	0.000414	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.08e-05	0.000414	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.04e-05	0.000409	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ENO2—urinary bladder cancer	2.91e-05	0.000391	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	2.91e-05	0.000391	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.84e-05	0.000381	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.83e-05	0.00038	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	2.82e-05	0.000379	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.82e-05	0.000378	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.72e-05	0.000365	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.72e-05	0.000365	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.66e-05	0.000357	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.62e-05	0.000351	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.56e-05	0.000344	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.54e-05	0.000341	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.53e-05	0.00034	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.51e-05	0.000338	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.51e-05	0.000338	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.5e-05	0.000336	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.44e-05	0.000328	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.43e-05	0.000327	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.41e-05	0.000323	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.41e-05	0.000323	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.4e-05	0.000322	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.4e-05	0.000322	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NQO1—urinary bladder cancer	2.34e-05	0.000315	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.34e-05	0.000314	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.3e-05	0.000309	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ERCC2—urinary bladder cancer	2.26e-05	0.000304	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.21e-05	0.000297	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.13e-05	0.000285	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.05e-05	0.000275	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.05e-05	0.000275	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.03e-05	0.000273	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.03e-05	0.000272	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.98e-05	0.000267	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.97e-05	0.000264	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.96e-05	0.000263	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.95e-05	0.000262	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.87e-05	0.000251	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.82e-05	0.000244	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.8e-05	0.000241	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.8e-05	0.000241	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.72e-05	0.000231	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.72e-05	0.000231	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.72e-05	0.00023	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.69e-05	0.000227	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.69e-05	0.000227	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.69e-05	0.000227	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.66e-05	0.000222	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.65e-05	0.000222	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.64e-05	0.00022	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.6e-05	0.000215	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.59e-05	0.000213	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.57e-05	0.000211	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.55e-05	0.000209	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.55e-05	0.000209	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.49e-05	0.0002	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.46e-05	0.000196	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.46e-05	0.000196	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.4e-05	0.000187	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.38e-05	0.000185	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.37e-05	0.000184	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.36e-05	0.000182	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.35e-05	0.000181	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.35e-05	0.000181	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.33e-05	0.000179	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.31e-05	0.000176	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.29e-05	0.000173	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.28e-05	0.000172	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.26e-05	0.00017	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.26e-05	0.00017	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.24e-05	0.000166	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.21e-05	0.000163	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.19e-05	0.00016	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.18e-05	0.000159	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—EP300—urinary bladder cancer	1.13e-05	0.000151	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.12e-05	0.00015	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.11e-05	0.000149	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.09e-05	0.000146	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.07e-05	0.000144	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	0.000136	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9.07e-06	0.000122	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	9.06e-06	0.000122	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTEN—urinary bladder cancer	8.84e-06	0.000119	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	8.76e-06	0.000118	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	8.7e-06	0.000117	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.44e-06	0.000113	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—EP300—urinary bladder cancer	8.43e-06	0.000113	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.34e-06	0.000112	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.34e-06	0.000112	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.99e-06	0.000107	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.84e-06	0.000105	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	7.64e-06	0.000103	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.37e-06	9.9e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—EP300—urinary bladder cancer	7.28e-06	9.78e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.13e-06	9.57e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.22e-06	8.35e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.98e-06	8.02e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—EP300—urinary bladder cancer	5.93e-06	7.96e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.74e-06	7.71e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.7e-06	6.31e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.1e-06	5.51e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.91e-06	5.25e-05	CbGpPWpGaD
